=== PAGE 36 ===

COMPLETE PAGE ANALYSIS:
--------------------------------------------------
Here is the text content from the PDF page, preserving its original layout and structure:

(Pink vertical bar on the left edge, next to a wide light blue horizontal bar)
Important Safety Information (Cont.)

CONTRAINDICATIONS
* A high risk of arterial or venous thrombotic diseases
* Current or history of a hormonally sensitive malignancy (eg, breast cancer)
* Hepatic adenoma, hepatocellular carcinoma, acute hepatitis, or decompensated cirrhosis
* Coadministration with hepatitis C drug combination (ombitasvir/paritaprevir/ritonavir, with or without
  dasabuvir)
* Abnormal uterine bleeding that has an undiagnosed etiology
* Renal impairment
* Adrenal insufficiency

(Black circular logo with "maynepharma" in white text inside)

35                                                                              Full Prescribing Information is available at www.Nextstellis.com
